Clinical Trial Update: Lundbeck TOMs Orthostatic Hypotension [Phase 4]

View source ↗

Summary

A Phase 4 trial update for Lundbeck TOMs addressing orthostatic hypotension in patients with idiopathic Parkinson disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease
• Orthostatic Hypotension

Drugs mentioned

• TOMs

Snippet

Sponsor: Alberto Espay, MD, MSc | Conditions: Orthostatic Hypotension, Idiopathic Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2022-09-26